GGrantIndex
Sort

141,003 grants matching cytokine

Substance Use and Immunity in HIV+ Adolescents by Systems Biology

$948,825
Maureen M Goodenow · University Of Florida · R01 · FY2010 · DA

Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.

$948,518
Srikant Rangaraju · Yale University · R01 · FY2025 · AG

Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)

$948,453
David W Crabb · Indiana University Indianapolis · U01 · FY2012 · AA

Novel Stem Cell Immunotherapy for MDR-Tuberculosis

$948,345
Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI

Epigenetic Regulation of T cell differentiation

$948,345
Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

programmed cell death in regulation of autoimmunity

$948,335
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2010 · AR

TL1A and its receptor DR3 in normal and autoimmune T cell responses

$948,335
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2010 · AR

The functional significance of CTL escape

$948,180
David I Watkins · University Of Miami School Of Medicine · R01 · FY2019 · AI

Combining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma

$948,099
Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2023 · CA

Molecular Epidemiology of Testicular Carcinoma

$948,055
Stephen Marc Schwartz · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA

Prediction of Alcohol Use Disorder and PTSD After Trauma in Adolescents

$947,876
Charles B Nemeroff · University Of Texas At Austin · R01 · FY2022 · AA

Improving Functioning in Peripheral Arterial Disease

$947,146
Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2007 · HL

Program to promote lung regeneration and block fibrosis

$947,046
Harold A Chapman · University Of California, San Francisco · R35 · FY2024 · HL

Oral Microbial and Immunological Characterization of Patients with Immune Dysfun

$947,033
Niki Moutsopoulos · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE

Mechanisms of Chronic Inflammation in Periodontitis

$947,033
Niki Moutsopoulos · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE

Targeting Blys/Baff in non-human primate islet transplantation

$947,016
Ali Naji · University Of Pennsylvania · U01 · FY2016 · AI

Immunopathogenesis of Fungal Infections

$946,840
Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Leptin as a Therapy for Alzheimer's Disease

$946,570
Nikolaos Tezapsidis · Neurotez, Inc. · R44 · FY2011 · AG

Virologic Correlates of Heterosexual Transmission

$946,499
Eric Hunter · Emory University · R37 · FY2016 · AI

Structure and Function of APOBEC Proteins

$946,233
Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

TNF-receptors and programmed cell death in regulation of autoimmunity

$946,219
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2017 · AR

Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)

$945,993
Vikas R. Dharnidharka · Rutgers Biomedical And Health Sciences · U01 · FY2025 · CA

Host defense-stimulating macrocyclic peptides for treatment of MDR bacterial infections

$945,797
Michael E Selsted · University Of Southern California · R01 · FY2018 · AI

Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues

$945,780
Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2023 · AI

Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer

$945,646
Eliseu O. De Oliveira · Coare Holdings, Inc. · R44 · FY2022 · CA